Loading candles…
Mangalam Drugs & Organics Ltd, incorporated in 1977, operates in the pharmaceutical industry focusing on the manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates. The company has established a notable presence in the global anti-malarial segment, backed by approvals from major international health organizations. Its business segments include the production of APIs and intermediates used in drug manufacturing. No specific information is provided on its founders, key management, headquarters, subsidiaries, or stock listings.
This page is a live market overview for MANGALAM DRUG & CHEM LTD (MANGALAM) on the NSE. As a listed security, MANGALAM DRUG & CHEM LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for MANGALAM before placing trades on tick2trade.
As of the latest feed, MANGALAM last traded at ₹32.2 on NSE, down ₹0.04 (0.12%) from the previous close of ₹32.24. Today's session range is ₹32.06 – ₹34.3, against a 52-week band of ₹22.8 – ₹77.6. Traded volume today stands at 39.08K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for MANGALAM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether MANGALAM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for MANGALAM DRUG & CHEM LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in MANGALAM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated MANGALAM option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 12 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 14 May 2026 |
| Other | To consider other business matters | 26 Mar 2026 |
| Other | To consider other business matters | 6 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 15 Jan 2026 |
| Results - FY25 | MANGALAM : 20-Nov-2025 : The Company has informed the Exchange that a Board meeting to be held on November 13, 2025 has been re-scheduled. Further, the Comp… | 20 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Intimation | Board Meeting Intimation to be held on 5th September, 2025 for approval of Appointment of Secretarial Auditor of the Company for the period of 5 Years and re… | 5 Sep 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.